Biologics CDMO Market 2024-2031: Unveiling Key Trends and Opportunities in the Booming Biopharma Landscape
JERSEY, NJ, US, April 4, 2024 /EINPresswire.com/ -- “Biologics CDMO Market” in terms of revenue was estimated to be worth $21.09 billion in 2023 and is poised to reach $68.97 billion by 2031, growing at a CAGR of 16.18% from 2024 to 2031 according to a …